Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We are pleased to announce that both ISS and Glass Lewis have recommended that our shareholders vote for the combination of Aphria Inc. and @Tilray.
https://aphriainc.com/iss-and-glass-lewis-recommend-shareholders-vote-for-the-proposed-aphria-tilray-business-combination/
POLITICSSchumer Says Bill To Legalize Marijuana Federally Will Be Filed ‘Shortly’Published 17 hours ago on March 31, 2021 By Kyle Jaeger
SHARE TWEET
Senate Majority Leader Chuck Schumer (D-NY) said on Wednesday that a bill to federally legalize marijuana will be introduced imminently in the Senate.
He made the comments on the same day that the governor of his home state signed a bill to legalize adult-use cannabis in New York, making possession of up to three ounces of marijuana by adults 21 and older immediately lawful.
“I support decriminalization at the federal level,” Schumer said, “and we’ll be introducing legislation with a few of my colleagues shortly.”
Asked to clarify whether he supports legalization, Schumer replied, “decriminalization, legalization,” implying that the two terms are used interchangeably.
“At the federal level, you call it ‘decriminalization’ because that lets the states legalize,” he said. But in general, advocates draw a distinction between the terms, with decriminalization usually being used to describe state or local policies that simply remove the threat of incarceration for simple possession while fines or other penalties could still be levied, which is distinct from outright legalization.
“The Marijuana Regulation and Taxation Act legalizing marijuana is now law in New York,” Schumer tweeted separately on Wednesday. “And I will keep working in the Senate to end the federal prohibition on marijuana and undo the damage of the War on Drugs.”
The majority leader has teamed up this session with Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ) to craft legislation to end federal cannabis prohibition. They started by holding a meeting with representatives from a variety of advocacy groups to gain feedback on the best approach to the reform.
While the text of the bill hasn’t been filed yet and few details have been discussed, it’s expected to remove marijuana from the list of federally controlled substances and promote social equity.
Schumer made a point earlier this month to say that it will specifically seek to restrict the ability of large alcohol and tobacco companies to overtake the industry.
Instead, it will prioritize small businesses, particularly those owned by people from communities most impacted by prohibition, and focus on “justice, justice, justice—as well as freedom,” he said.
He also urged voters to reach out to their congressional representatives and tell them that “this is long overdue.”
Schumer, who also included cannabis legalization as a legislative priority in a recent fundraising email to his list of supporters, said that the American people recognize that prohibition has failed and “so many lives have been wasted because marijuana has been listed as something as bad as heroin” under federal law.
On the House side, Judiciary Chairman Jerrold Nadler (D-NY) said recently that he plans to reintroduced his legalization bill, the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, which cleared the chamber last year but did not advance in the Senate under GOP control.
Now that Democrats have the majority in both chambers, as well as the White House, there’s a sense of optimism among advocates that comprehensive reform is achievable in this Congress.
But with respect to the White House, Press Secretary Jen Psaki said on Tuesday that President Joe Biden’s position on adult-use legalization “has not changed,” meaning he still opposes the policy. He hasn’t said whether he would sign or veto a bill to enact the policy change if it arrived on his desk, however.
The president instead backs modestly rescheduling the plant, decriminalizing possession, legalizing medical cannabis, expunging prior marijuana records and letting states set their own policies.
Like investing in Anheuser-Busch near the end of prohibition Laser..also: Will Aphria/Tilray Profit From U.S. Weed Legalization?
Andrew Button
Wed, March 31, 2021, 12:45 PM·3 min read
APHA
+4.32%
TLRY
+3.13%
Cannabis leaves of a plant on a dark background
Cannabis leaves of a plant on a dark background
Marijuana legalization is coming to the United States.
Just recently, New York lawmakers moved to legalize cannabis in their state. That came after other states like California and Colorado legalized recreational cannabis use. With two of the most influential States having legalized cannabis, it seems like only a matter of time until Joe Biden pursues federal-level decriminalization.
This is a significant development. And Canadian pot firm Aphria (TSX:APHA)(NASDAQ:APHA) stands to gain from it. Thanks to its upcoming merger with Tilray (NASDAQ:TLRY), Aphria will have a substantial physical presence in the United States. That may give it an advantage when selling in that market. In this article, I’ll explore how much money Aphria/Tilray could make from U.S. weed legalization.
How much Aphria/Tilray could make from the merger
According to New Frontier, the U.S. legal marijuana industry was worth $13.6 billion in 2019. The more states legalize cannabis, the higher that figure is likely to go.
Currently, there are a number of companies supplying recreational and medical marijuana to the United States. That includes both Canadian firms and home-grown U.S. operations like Tilray. If the new Aphria/Tilray company were able to grab 20% of the U.S. marijuana industry, based on 2019 sales numbers, it would generate $2.72 billion in revenue.
Of course, total legal marijuana sales are likely to be higher in the future, and 20% is just an estimate. But even figuring fairly conservatively, we can see that there is significant potential revenue to be gained here. Tilray is probably already getting a nice share of the U.S. marijuana revenue just mentioned. Once the Aphria/Tilray merger closes, APHA investors will get a chunk of it as well. So, for Canadian investors holding APHA stock but not TLRY stock, this is “new” revenue.
How much will current Aphria investors get?
The biggest positive of the Aphria/Tilray merger for Aphria investors is that Aphria is getting the better end of the deal. Aphria shareholders will get 68% of the newly formed company. Therefore, the deal will increase Aphria’s stock value. Based on the value of the Tilray shares Aphria is to receive, APHA technically traded at a discount briefly this year. This made it one of the easiest arbitrage opportunities in recent stock market history, though APHA’s stock price has since closed the gap.
Foolish takeaway
In recent years, there hasn’t been a whole lot of interest in cannabis stocks. After Canadian legalization underwhelmed investors, the cannabis industry went dormant — at least in the media. That’s beginning to change. With U.S. legalization looming and the sector’s biggest-ever merger set to close, we could see another speculative rally in cannabis stocks. Or, at least, more media coverage.
As of right now, it’s unclear whether Joe Biden will move to decriminalize marijuana in the United States. But it’s abundantly clear that more and more states are already moving in that direction. As this trend develops, Aphria/Tilray will likely get a lot of the new revenue generated. That’s a boon for Aphria shareholders, who will own the lion’s share of the newly formed company.
The post Will Aphria/Tilray Profit From U.S. Weed Legalization? appeared first on The Motley Fool Canada.
Like investing in Anheuser-Busch near the end of prohibition Laser..also: Will Aphria/Tilray Profit From U.S. Weed Legalization?
Andrew Button
Wed, March 31, 2021, 12:45 PM·3 min read
APHA
+4.32%
TLRY
+3.13%
Cannabis leaves of a plant on a dark background
Cannabis leaves of a plant on a dark background
Marijuana legalization is coming to the United States.
Just recently, New York lawmakers moved to legalize cannabis in their state. That came after other states like California and Colorado legalized recreational cannabis use. With two of the most influential States having legalized cannabis, it seems like only a matter of time until Joe Biden pursues federal-level decriminalization.
This is a significant development. And Canadian pot firm Aphria (TSX:APHA)(NASDAQ:APHA) stands to gain from it. Thanks to its upcoming merger with Tilray (NASDAQ:TLRY), Aphria will have a substantial physical presence in the United States. That may give it an advantage when selling in that market. In this article, I’ll explore how much money Aphria/Tilray could make from U.S. weed legalization.
How much Aphria/Tilray could make from the merger
According to New Frontier, the U.S. legal marijuana industry was worth $13.6 billion in 2019. The more states legalize cannabis, the higher that figure is likely to go.
Currently, there are a number of companies supplying recreational and medical marijuana to the United States. That includes both Canadian firms and home-grown U.S. operations like Tilray. If the new Aphria/Tilray company were able to grab 20% of the U.S. marijuana industry, based on 2019 sales numbers, it would generate $2.72 billion in revenue.
Of course, total legal marijuana sales are likely to be higher in the future, and 20% is just an estimate. But even figuring fairly conservatively, we can see that there is significant potential revenue to be gained here. Tilray is probably already getting a nice share of the U.S. marijuana revenue just mentioned. Once the Aphria/Tilray merger closes, APHA investors will get a chunk of it as well. So, for Canadian investors holding APHA stock but not TLRY stock, this is “new” revenue.
How much will current Aphria investors get?
The biggest positive of the Aphria/Tilray merger for Aphria investors is that Aphria is getting the better end of the deal. Aphria shareholders will get 68% of the newly formed company. Therefore, the deal will increase Aphria’s stock value. Based on the value of the Tilray shares Aphria is to receive, APHA technically traded at a discount briefly this year. This made it one of the easiest arbitrage opportunities in recent stock market history, though APHA’s stock price has since closed the gap.
Foolish takeaway
In recent years, there hasn’t been a whole lot of interest in cannabis stocks. After Canadian legalization underwhelmed investors, the cannabis industry went dormant — at least in the media. That’s beginning to change. With U.S. legalization looming and the sector’s biggest-ever merger set to close, we could see another speculative rally in cannabis stocks. Or, at least, more media coverage.
As of right now, it’s unclear whether Joe Biden will move to decriminalize marijuana in the United States. But it’s abundantly clear that more and more states are already moving in that direction. As this trend develops, Aphria/Tilray will likely get a lot of the new revenue generated. That’s a boon for Aphria shareholders, who will own the lion’s share of the newly formed company.
The post Will Aphria/Tilray Profit From U.S. Weed Legalization? appeared first on The Motley Fool Canada.
@senschumer: 1:01pm 3/31/21 “The Marijuana Regulation and Taxation Act legalizing marijuana is now law in New York.
And I will keep working in the Senate to end the federal prohibition on marijuana and undo the damage of the War on Drugs.”
@senschumer: 1:01pm 3/31/21 “The Marijuana Regulation and Taxation Act legalizing marijuana is now law in New York.
And I will keep working in the Senate to end the federal prohibition on marijuana and undo the damage of the War on Drugs.”
04/12/21: APHRIA Earnings
04/14/21: APHRIA merger vote
04/16/21: TILRAY merger vote
04/20/21: APHRIA/TILRAY Schedule merger
05/13/21: TILRAY Earnings
4/1 is Thursday.
04/12/21: APHRIA Earnings
04/14/21: APHRIA merger vote
04/16/21: TILRAY merger vote
04/20/21: APHRIA/TILRAY Schedule merger
05/13/21: TILRAY Earnings
4/1 is Thursday.
Marijuana takes center stage in New Mexico special session
By MORGAN LEE
today
https://apnews.com/article/michelle-lujan-grisham-new-mexico-recreational-marijuana-marijuana-f5d791226eac84ac475d1c935fae9d7f?utm_campaign=SocialFlow&utm_medium=AP&utm_source=Twitter
Marijuana takes center stage in New Mexico special session
By MORGAN LEE
today
https://apnews.com/article/michelle-lujan-grisham-new-mexico-recreational-marijuana-marijuana-f5d791226eac84ac475d1c935fae9d7f?utm_campaign=SocialFlow&utm_medium=AP&utm_source=Twitter
New York officials reach agreement to legalize marijuana
By Bernadette Hogan, Carl Campanile and Bruce Golding
March 24, 2021 | 3:05pm
https://nypost.com/2021/03/24/new-york-officials-reach-agreement-to-legalize-marijuana/
New York officials reach agreement to legalize marijuana
By Bernadette Hogan, Carl Campanile and Bruce Golding
March 24, 2021 | 3:05pm
https://nypost.com/2021/03/24/new-york-officials-reach-agreement-to-legalize-marijuana/
SAFE Banking Act Reintroduced tomorrow! Momentum builds for Cannabis Reform. It’s coming!
"The SAFE Banking Act further prevents regulators from taking a corrective supervisory action on a loan made to a person or entity solely because the loan is affiliated with a cannabis-related business. Loans designed for leasing real estate and equipment to cannabis businesses are explicitly protected."
SAFE Banking Act Reintroduced tomorrow! Momentum builds for Cannabis Reform. It’s coming!
"The SAFE Banking Act further prevents regulators from taking a corrective supervisory action on a loan made to a person or entity solely because the loan is affiliated with a cannabis-related business. Loans designed for leasing real estate and equipment to cannabis businesses are explicitly protected."
Per the coming conversion rate of .83 with TLRY, today we are sitting at $25.29 per share
We went up $5.29 today overall
Pot stocks rise in premarket after Mexico passes bill to legalize recreational use
https://seekingalpha.com/amp/news/3671656-pot-stocks-rise-in-premarket-after-mexico-passes-bill-to-legalize-recreational-use
Pot stocks rise in premarket after Mexico passes bill to legalize recreational use
https://seekingalpha.com/amp/news/3671656-pot-stocks-rise-in-premarket-after-mexico-passes-bill-to-legalize-recreational-use
If this were true this would bring them to $500… In my opinion
If this were true this would bring them to $500… In my opinion
High dose CBD study finds stunning potential for treating Alzheimer’s
https://www.slashgear.com/high-dose-cbd-study-finds-stunning-potential-for-treating-alzheimers-09663010/amp/
High dose CBD study finds stunning potential for treating Alzheimer’s
https://www.slashgear.com/high-dose-cbd-study-finds-stunning-potential-for-treating-alzheimers-09663010/amp/
"In addition to supplying hospitals and pharmacies, Tilray is a proud partner with several leading research institutions, including the Murdoch Children's Research Institute in Australia, studying the effectiveness of Tilray medical cannabis as a treatment for pediatric patients with Intellectual Disabilities suffering from Severe Behavioral Problems; a clinical trial in partnership with The Government of New South Wales and University of Sydney Chris O'Brien Lifehouse to develop a novel treatment for chemotherapy-induced nausea, and a study led by the University of Sydney examining the effects of driving under the influence of cannabis."
"In addition to supplying hospitals and pharmacies, Tilray is a proud partner with several leading research institutions, including the Murdoch Children's Research Institute in Australia, studying the effectiveness of Tilray medical cannabis as a treatment for pediatric patients with Intellectual Disabilities suffering from Severe Behavioral Problems; a clinical trial in partnership with The Government of New South Wales and University of Sydney Chris O'Brien Lifehouse to develop a novel treatment for chemotherapy-induced nausea, and a study led by the University of Sydney examining the effects of driving under the influence of cannabis."
Uhm.. merger in 6 weeks To make the biggest And most profitable cannabis company in the world right at the end of prohibition? IMO
Loading more
Loading more
Yeah let’s bail from the alcohol company stocks as prohibition is ending…
Not much of a bump for CGC despite being on Cramer last night. TLRY up in pre market 4x more in volume and sp.
Not much of a bump for CGC despite being on Cramer last night. TLRY up in pre market 4x more in volume and sp.
Canopy on Cramer tonight
Canopy on Cramer tonight
Not 4/20? Lol
And with the additional bonus of this being like alcohol having medicinal qualities?!
Re: FUNMAN “That Reddit thing was wild. I sold a buck and change below the top for a 10+ bagger. Holding a boat load of sub $6 APHA for conversion.”
Same. But I’m not unloading any of my APHA 6’s until NFLX territory. Then I’ll retire. This is like investing in alcohol as prohibition is ending.
Re: FUNMAN “That Reddit thing was wild. I sold a buck and change below the top for a 10+ bagger. Holding a boat load of sub $6 APHA for conversion.”
Same. But I’m not unloading any of my APHA 6’s until NFLX territory. Then I’ll retire. This is like investing in alcohol as prohibition is ending.
Starting in April $TLRY cannabis flower will be available in Portuguese pharmacies.
15 grams for 150 € at retail.
This is the first cannabis product approved by the Portuguese health agency, but other are in the pipeline
https://t.co/h2neXEiS0g
Starting in April $TLRY cannabis flower will be available in Portuguese pharmacies.
— Alfredo Pascual, CFA 🥨🧉 (@alfrep28) February 25, 2021
15 grams for 150 € at retail.
This is the first cannabis product approved by the Portuguese health agency, but other are in the pipeline.https://t.co/h2neXEiS0g